FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2296932421> ?p ?o ?g. }

• W2296932421 endingPage "e0151406" @default.
• W2296932421 startingPage "e0151406" @default.
• W2296932421 abstract "Background Ampulla of Vater cancer (AoV Ca) is a rare tumor, and its adjuvant treatment has not been established. The purpose of this study was to find out prognostic factors including host immunity and role of adjuvant treatment in AoV Ca. Methods and Findings We reviewed 227 AoV Ca patients with curative resection. Clinical characteristics, adjuvant treatment, disease-free survival (DFS) and overall survival (OS) were analyzed. Among all patients, 63.9, 36.1 and 33.9% had T1/T2, T3/T4 stage and lymph node-positive disease (LN+), respectively. OS of all patients was 90.9 months (95% CI: 52.9–129.0). OS was different according to neutrophil-to-lymphocyte ratio (HR 1.651, 95% CI: 1.11–2.47), platelet-to-lymphocyte ratio (HR 1.488, 95% CI: 1.00–2.21) and systemic inflammatory index (HR 1.669, 95% CI: 1.13–2.47). In multivariate analysis, adverse prognostic factors for OS included vascular invasion (HR 2.571, 95% CI: 1.20–5.53) and elevated CA 19–9 (HR 1.794, 95% CI: 1.07–3.05). A total of 104 patients (46.3%) received adjuvant treatment (25 out of 111of T1/T2 & LN (-), 79 out of 116 of T3/T4 or LN (+)). In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the longest OS (5-year OS rate: 47.0 vs. 41.4%). Conclusions Vascular invasion and elevated CA 19–9 were adverse prognostic factors in resected AoV Ca. In T3/T4 or LN (+) stage, adjuvant CCRT with maintenance chemotherapy provided the best survival outcome. Adjuvant treatment should be further defined in AoV Ca, especially with poor prognostic factors." @default.
• W2296932421 created "2016-06-24" @default.
• W2296932421 creator A5007110659 @default.
• W2296932421 creator A5011410839 @default.
• W2296932421 creator A5013664294 @default.
• W2296932421 creator A5028906808 @default.
• W2296932421 creator A5029996030 @default.
• W2296932421 creator A5035168521 @default.
• W2296932421 creator A5042323474 @default.
• W2296932421 creator A5047156899 @default.
• W2296932421 creator A5047219538 @default.
• W2296932421 creator A5057421700 @default.
• W2296932421 creator A5078338048 @default.
• W2296932421 creator A5078630835 @default.
• W2296932421 creator A5088893123 @default.
• W2296932421 date "2016-03-14" @default.
• W2296932421 modified "2023-10-14" @default.
• W2296932421 title "Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer" @default.
• W2296932421 cites W1697983669 @default.
• W2296932421 cites W1949584779 @default.
• W2296932421 cites W1968648909 @default.
• W2296932421 cites W1983088783 @default.
• W2296932421 cites W1984052587 @default.
• W2296932421 cites W1988082986 @default.
• W2296932421 cites W1991431093 @default.
• W2296932421 cites W2008762050 @default.
• W2296932421 cites W2010958420 @default.
• W2296932421 cites W2013562942 @default.
• W2296932421 cites W2020684281 @default.
• W2296932421 cites W2021679992 @default.
• W2296932421 cites W2024099956 @default.
• W2296932421 cites W2027996075 @default.
• W2296932421 cites W2030921519 @default.
• W2296932421 cites W2034770797 @default.
• W2296932421 cites W2045217572 @default.
• W2296932421 cites W2078233425 @default.
• W2296932421 cites W2094798668 @default.
• W2296932421 cites W2103810349 @default.
• W2296932421 cites W2107934474 @default.
• W2296932421 cites W2115812130 @default.
• W2296932421 cites W2117692326 @default.
• W2296932421 cites W2118278569 @default.
• W2296932421 cites W2120338564 @default.
• W2296932421 cites W2142300779 @default.
• W2296932421 cites W2148899606 @default.
• W2296932421 cites W2149422956 @default.
• W2296932421 cites W2166497065 @default.
• W2296932421 cites W2915373011 @default.
• W2296932421 doi "https://doi.org/10.1371/journal.pone.0151406" @default.
• W2296932421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4790941" @default.
• W2296932421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26974670" @default.
• W2296932421 hasPublicationYear "2016" @default.
• W2296932421 type Work @default.
• W2296932421 sameAs 2296932421 @default.
• W2296932421 citedByCount "14" @default.
• W2296932421 countsByYear W22969324212017 @default.
• W2296932421 countsByYear W22969324212019 @default.
• W2296932421 countsByYear W22969324212020 @default.
• W2296932421 countsByYear W22969324212021 @default.
• W2296932421 countsByYear W22969324212023 @default.
• W2296932421 crossrefType "journal-article" @default.
• W2296932421 hasAuthorship W2296932421A5007110659 @default.
• W2296932421 hasAuthorship W2296932421A5011410839 @default.
• W2296932421 hasAuthorship W2296932421A5013664294 @default.
• W2296932421 hasAuthorship W2296932421A5028906808 @default.
• W2296932421 hasAuthorship W2296932421A5029996030 @default.
• W2296932421 hasAuthorship W2296932421A5035168521 @default.
• W2296932421 hasAuthorship W2296932421A5042323474 @default.
• W2296932421 hasAuthorship W2296932421A5047156899 @default.
• W2296932421 hasAuthorship W2296932421A5047219538 @default.
• W2296932421 hasAuthorship W2296932421A5057421700 @default.
• W2296932421 hasAuthorship W2296932421A5078338048 @default.
• W2296932421 hasAuthorship W2296932421A5078630835 @default.
• W2296932421 hasAuthorship W2296932421A5088893123 @default.
• W2296932421 hasBestOaLocation W22969324211 @default.
• W2296932421 hasConcept C121608353 @default.
• W2296932421 hasConcept C126322002 @default.
• W2296932421 hasConcept C143998085 @default.
• W2296932421 hasConcept C146357865 @default.
• W2296932421 hasConcept C151730666 @default.
• W2296932421 hasConcept C197934379 @default.
• W2296932421 hasConcept C2777546739 @default.
• W2296932421 hasConcept C2777863537 @default.
• W2296932421 hasConcept C2777982462 @default.
• W2296932421 hasConcept C2780840399 @default.
• W2296932421 hasConcept C2780849966 @default.
• W2296932421 hasConcept C71924100 @default.
• W2296932421 hasConcept C86803240 @default.
• W2296932421 hasConcept C90924648 @default.
• W2296932421 hasConceptScore W2296932421C121608353 @default.
• W2296932421 hasConceptScore W2296932421C126322002 @default.
• W2296932421 hasConceptScore W2296932421C143998085 @default.
• W2296932421 hasConceptScore W2296932421C146357865 @default.
• W2296932421 hasConceptScore W2296932421C151730666 @default.
• W2296932421 hasConceptScore W2296932421C197934379 @default.
• W2296932421 hasConceptScore W2296932421C2777546739 @default.
• W2296932421 hasConceptScore W2296932421C2777863537 @default.
• W2296932421 hasConceptScore W2296932421C2777982462 @default.

• next